Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
N-able
NABL
$1.58B
| $1.67M | ﹤0.01% |
125,850
-14,200
| -10% | -$188K |
|
1952
Astec Industries
ASTE
$1.09B
| $1.67M | ﹤0.01% |
44,800
-5,200
| -10% | -$193K |
|
1953
Unitil
UTL
$832M
| $1.67M | ﹤0.01% |
31,700
-3,700
| -10% | -$195K |
|
1954
Lemonade
LMND
$3.73B
| $1.66M | ﹤0.01% |
103,000
-11,500
| -10% | -$185K |
|
|
PGRE
1955
Paramount Group
PGRE
$1.59B
| $1.66M | ﹤0.01% |
321,143
-37,000
| -10% | -$191K |
|
1956
Clearway Energy Class A
CWEN.A
$3.21B
| $1.66M | ﹤0.01% |
64,850
-7,500
| -10% | -$192K |
|
1957
First Advantage
FA
$2.83B
| $1.66M | ﹤0.01% |
100,100
-12,400
| -11% | -$205K |
|
|
AHH
1958
Armada Hoffler Properties
AHH
$596M
| $1.66M | ﹤0.01% |
133,900
-15,400
| -10% | -$190K |
|
1959
ANI Pharmaceuticals
ANIP
$2.14B
| $1.65M | ﹤0.01% |
30,000
-5,500
| -15% | -$303K |
|
1960
Powell Industries
POWL
$3.53B
| $1.65M | ﹤0.01% |
18,700
-2,200
| -11% | -$194K |
|
1961
Mativ Holdings
MATV
$680M
| $1.65M | ﹤0.01% |
107,812
-12,700
| -11% | -$194K |
|
1962
Capitol Federal Financial
CFFN
$855M
| $1.64M | ﹤0.01% |
255,000
-29,300
| -10% | -$189K |
|
|
MORF
1963
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.64M | ﹤0.01% |
56,700
-2,700
| -5% | -$78K |
|
1964
Symbotic
SYM
$5.44B
| $1.64M | ﹤0.01% |
31,900
-1,900
| -6% | -$97.5K |
|
1965
Aspen Aerogels
ASPN
$560M
| $1.64M | ﹤0.01% |
103,700
-11,900
| -10% | -$188K |
|
1966
Varex Imaging
VREX
$477M
| $1.63M | ﹤0.01% |
79,640
-9,200
| -10% | -$189K |
|
1967
Geron
GERN
$842M
| $1.63M | ﹤0.01% |
773,600
-232,900
| -23% | -$491K |
|
1968
Keros Therapeutics
KROS
$640M
| $1.63M | ﹤0.01% |
40,900
-4,700
| -10% | -$187K |
|
|
ACCD
1969
DELISTED
Accolade, Inc. Common Stock
ACCD
| $1.62M | ﹤0.01% |
135,200
-14,400
| -10% | -$173K |
|
1970
TFS Financial
TFSL
$3.78B
| $1.62M | ﹤0.01% |
110,500
-12,700
| -10% | -$187K |
|
1971
Core Laboratories
CLB
$594M
| $1.62M | ﹤0.01% |
91,900
-10,600
| -10% | -$187K |
|
|
FBMS
1972
DELISTED
The First Bancshares, Inc.
FBMS
| $1.62M | ﹤0.01% |
55,230
-6,200
| -10% | -$182K |
|
1973
Dream Finders Homes
DFH
$2.8B
| $1.61M | ﹤0.01% |
45,400
-4,800
| -10% | -$171K |
|
1974
AdvanSix
ASIX
$586M
| $1.61M | ﹤0.01% |
53,700
-6,900
| -11% | -$207K |
|
1975
Pliant Therapeutics
PLRX
$101M
| $1.6M | ﹤0.01% |
88,400
-2,700
| -3% | -$48.9K |
|